Keith Brown, MBA

Chief Executive Officer - TissueGen

Keith is President and CEO of TissueGen, Inc.  TissueGen is a medical device company whose patented technology enables creation of biodegradable polymer devices with unique drug delivery capabilities.  TissueGen is focusing initial product development efforts on vascular stents, and became an NTEC program company in 2005.

Prior to joining TissueGen, Keith had 15 years experience with venture-backed biotechnology companies following 10 years in the medical diagnostics industry.  He was the founding President/CEO of GeneScreen, building it into a $15 million, multi-location laboratory testing company in the field of DNA analysis.  GeneScreen was sold to Orchid BioSciences in 2000 where Keith managed their Identity Genomics business to over $30 million.  Keith's experience includes leading five rounds of venture financing with GeneScreen and assisting in Orchid's IPO, four acquisitions, two divestitures, and all aspects of budgeting, financing, marketing, sales, operations and strategic business planning.  He obtained his Master of Business Administration degree with distinction from Harvard School of Business in 1978.